Definition

A drug used to treat adults with uveal melanoma (a type of eye cancer) that has spread or cannot be removed by surgery. It is used in patients who have the HLA-A*02:01 antigen. It is also being studied in the treatment of other types of cancer. Kimmtrak binds to certain antigens found on the surfaces of uveal melanoma cells and T cells (a type of immune cell). This may help the immune system kill cancer cells. Kimmtrak is a type of bispecific fusion protein. Also called tebentafusp.